Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone is a synthetic organic compound with the molecular formula C22H21NO2S. It is characterized by a pyrrolidine ring, a thiophene group, and a methanone linkage. While its chemical structure is well-defined and available in public databases like PubChem, specific information regarding its mechanism of action, therapeutic indications, and development status as a drug is not readily available in the public domain. It is likely a research chemical or an early-stage compound without established pharmacological properties or clinical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [4-[[(2R)-pyrrolidin-2-yl]methoxy]phenyl]-(4-thiophen-3-ylphenyl)methanone.